Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
9.60 x 1 10.35 x 1
Post-market by (Cboe BZX)
9.73 -0.25 (-2.51%) 03/25/25 [NASDAQ]
9.60 x 1 10.35 x 1
Post-market 9.73 unch (unch) 16:43 ET
Quote Overview for Tue, Mar 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
9.64
Day High
10.14
Open 9.98
Previous Close 9.98 9.98
Volume 583,000 583,000
Avg Vol 1,072,915 1,072,915
Stochastic %K 26.27% 26.27%
Weighted Alpha -62.61 -62.61
5-Day Change -0.17 (-1.72%) -0.17 (-1.72%)
52-Week Range 9.36 - 29.30 9.36 - 29.30
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 911,264
  • Shares Outstanding, K 91,309
  • Annual Sales, $ 837,600 K
  • Annual Income, $ -127,300 K
  • EBIT $ -88 M
  • EBITDA $ 30 M
  • 60-Month Beta 1.79
  • Price/Sales 1.09
  • Price/Cash Flow 10.02
  • Price/Book 1.30

Options Overview Details

View History
  • Implied Volatility 69.10% ( +3.36%)
  • Historical Volatility 73.06%
  • IV Percentile 71%
  • IV Rank 60.39%
  • IV High 106.49% on 03/14/25
  • IV Low 12.10% on 06/03/24
  • Put/Call Vol Ratio 1.00
  • Today's Volume 4
  • Volume Avg (30-Day) 74
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 1,531
  • Open Int (30-Day) 2,119

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.17
  • Number of Estimates 6
  • High Estimate -0.15
  • Low Estimate -0.18
  • Prior Year -0.14
  • Growth Rate Est. (year over year) -21.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.36 +3.95%
on 03/10/25
Period Open: 11.74
11.89 -18.17%
on 02/26/25
-2.01 (-17.12%)
since 02/25/25
3-Month
9.36 +3.95%
on 03/10/25
Period Open: 13.74
15.47 -37.10%
on 02/19/25
-4.01 (-29.18%)
since 12/24/24
52-Week
9.36 +3.95%
on 03/10/25
Period Open: 21.98
29.30 -66.79%
on 09/18/24
-12.25 (-55.73%)
since 03/25/24

Most Recent Stories

More News
1 Small-Cap Stock on Our Watchlist and 2 to Avoid

1 Small-Cap Stock on Our Watchlist and 2 to Avoid

MYGN : 9.73 (-2.51%)
ENSG : 130.01 (-0.30%)
ESAB : 122.77 (-0.10%)
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack

MYGN : 9.73 (-2.51%)
VRTX : 509.04 (-0.53%)
BMRN : 71.53 (-0.64%)
GILD : 107.89 (+1.08%)
MRNA : 33.85 (-0.94%)
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings?

Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings?

COST : 930.26 (+0.46%)
MYGN : 9.73 (-2.51%)
Why Are Myriad Genetics (MYGN) Shares Soaring Today

Why Are Myriad Genetics (MYGN) Shares Soaring Today

MYGN : 9.73 (-2.51%)
Nasdaq Climbs as Retaliatory Tariffs Spark Mixed Session on Wall Street

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.43%. March E-mini S&P futures (ESH25...

GOOGL : 170.56 (+1.72%)
AMAT : 153.64 (-0.85%)
UAL : 78.90 (-1.65%)
AVGO : 188.26 (-1.56%)
VZ : 43.49 (-0.16%)
CROX : 112.59 (+1.51%)
GRPN : 18.24 (+1.39%)
BF.A : 33.16 (-0.30%)
$IUXX : 20,287.83 (+0.53%)
ZNM25 : 110-180 (-0.17%)
TSLA : 288.14 (+3.50%)
ESM25 : 5,826.75 (unch)
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks

MYGN : 9.73 (-2.51%)
BMRN : 71.53 (-0.64%)
GILD : 107.89 (+1.08%)
ABBV : 201.34 (-3.74%)
MRNA : 33.85 (-0.94%)
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4

SRPT : 73.61 (-3.56%)
MYGN : 9.73 (-2.51%)
BMRN : 71.53 (-0.64%)
ABBV : 201.34 (-3.74%)
MRNA : 33.85 (-0.94%)
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools

MYGN : 9.73 (-2.51%)
Why Myriad Genetics (MYGN) Shares Are Plunging Today

Why Myriad Genetics (MYGN) Shares Are Plunging Today

MYGN : 9.73 (-2.51%)
Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

Sarepta Therapeutics (SRPT) To Report Earnings Tomorrow: Here Is What To Expect

SRPT : 73.61 (-3.56%)
MYGN : 9.73 (-2.51%)
BMRN : 71.53 (-0.64%)

Business Summary

Myriad Genetics employs a number of proprietary technologies to target the genetic basis of human diseases and the role these genes might play in the onset, progression and treatment of the respective diseases. The company has more than 10 proprietary molecular diagnostic products in market. It has made...

See More

Key Turning Points

3rd Resistance Point 10.53
2nd Resistance Point 10.34
1st Resistance Point 10.03
Last Price 9.73
1st Support Level 9.53
2nd Support Level 9.34
3rd Support Level 9.03

See More

52-Week High 29.30
Fibonacci 61.8% 21.68
Fibonacci 50% 19.33
Fibonacci 38.2% 16.98
Last Price 9.73
52-Week Low 9.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals